Biotech entrepreneur A2 Corp has reported a September half year loss of $226,000 compared with a $1.36 million loss a year ago.
Operating revenue increased by 263 per cent to $694,000, mainly due to the one-off US$400,000 invoiced to IdeaSphere for a licensing agreement and growth in royalties from Australia.
The result included a $20,000 debt writedown offset by a $16,000 writeback.
A2 loss decreases
AdvertisementAdvertise with NZME.
